Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Interferons adverse reaction |
Causative agent (attribute) |
True |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Human interferon gamma-1b adverse reaction |
Causative agent (attribute) |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon-A-2a adverse reaction (disorder) |
Causative agent (attribute) |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon-A-2b adverse reaction |
Causative agent (attribute) |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon-A-N1 adverse reaction |
Causative agent (attribute) |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon gamma assay |
Has measured component |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alpha assay |
Has measured component |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon assay |
Has measured component |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta assay (procedure) |
Has measured component |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon gamma assay |
Component |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alpha assay |
Component |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon assay |
Component |
True |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon beta assay (procedure) |
Component |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing interferon beta-1a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1b-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing interferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing interferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 10million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 5million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 3million iu injection (pdr for recon)+diluent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 1million iu injection (pdr for recon)+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 6million iu/mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18million iu/1mL injection solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1b 8million iu injection (pdr for recon)+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 6million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 4.5million iu/0.5mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 12million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 9million iu/0.5mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1a 6million iu injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 15million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 25million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 50million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 25million iu/2.5mL injection solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1a 12million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1a 12million iu/0.5mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18million iu/0.6mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 50micrograms injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 150micrograms injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 120micrograms injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing peginterferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing interferon beta (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfacon-130mcg/mL injection solution 0.3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1b 100mcg/ solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 5000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 25000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 50000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 10000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 3000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 18,000,000iu/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 25 millioniu/vial solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 18 millioniu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 10 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 3 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 5 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 30000000iu solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 60million/iu solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 150mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 300mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 120mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 600mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 100.000mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 50mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2a-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-n3 human leu 5000000unt/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 6miu/vial injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 9miu/vial injection solution 0.9mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 36000000iu/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 3miu/vial injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18000000iu/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 3miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1a 30mcg/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 150micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 120micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 50micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 80micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 10million iu/2mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18million iu/0.5mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1b 0.3mg powder for injection+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Injectable interferon |
Is a |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon gamma-1b (substance) |
Is a |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alpha-2a preparation |
Is a |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b |
Is a |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons allergy |
Causative agent (attribute) |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfacon-1 |
Is a |
True |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon gamma (substance) |
Is a |
True |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-n1 lymphoblastoid |
Is a |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-n3 (substance) |
Is a |
False |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa (substance) |
Is a |
True |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta |
Is a |
True |
Interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|